Showing 1 - 5 results of 5 for search 'Sheri L. Holmen', query time: 0.02s Refine Results
  1. 1
    First line immunotherapy extends brain metastasis free survival, improves overall survival, and reduces the incidence of brain metastasis in patients with advanced melanoma

    First line immunotherapy extends brain metastasis free survival, improves overall survival, and reduces the incidence of brain metastasis in patients with advanced melanoma by Xuechen Wang, Benjamin Haaland, Siwen Hu‐Lieskovan, Howard Colman, Sheri L. Holmen

    Published 2021-12-01
    Get full text
    Article
  2. 2
    Prior Exposure to Coxsackievirus A21 Does Not Mitigate Oncolytic Therapeutic Efficacy

    Prior Exposure to Coxsackievirus A21 Does Not Mitigate Oncolytic Therapeutic Efficacy by William J. Burnett, David M. Burnett, Gennie Parkman, Andrew Ramstead, Nico Contreras, William Gravley, Sheri L. Holmen, Matthew A. Williams, Matthew W. VanBrocklin

    Published 2021-09-01
    Get full text
    Article
  3. 3
    AKT1 Activation Promotes Development of Melanoma Metastases

    AKT1 Activation Promotes Development of Melanoma Metastases by Joseph H. Cho, James P. Robinson, Rowan A. Arave, William J. Burnett, David A. Kircher, Guo Chen, Michael A. Davies, Allie H. Grossmann, Matthew W. VanBrocklin, Martin McMahon, Sheri L. Holmen

    Published 2015-11-01
    Get full text
    Article
  4. 4
    Mutant IDH1 Promotes Glioma Formation In Vivo

    Mutant IDH1 Promotes Glioma Formation In Vivo by Beatrice Philip, Diana X. Yu, Mark R. Silvis, Clifford H. Shin, James P. Robinson, Gemma L. Robinson, Adam E. Welker, Stephanie N. Angel, Sheryl R. Tripp, Joshua A. Sonnen, Matthew W. VanBrocklin, Richard J. Gibbons, Ryan E. Looper, Howard Colman, Sheri L. Holmen

    Published 2018-05-01
    Get full text
    Article
  5. 5
    InterMEL: An international biorepository and clinical database to uncover predictors of survival in early-stage melanoma.

    InterMEL: An international biorepository and clinical database to uncover predictors of survival in early-stage melanoma. by Irene Orlow, Keimya D Sadeghi, Sharon N Edmiston, Jessica M Kenney, Cecilia Lezcano, James S Wilmott, Anne E Cust, Richard A Scolyer, Graham J Mann, Tim K Lee, Hazel Burke, Valerie Jakrot, Ping Shang, Peter M Ferguson, Tawny W Boyce, Jennifer S Ko, Peter Ngo, Pauline Funchain, Judy R Rees, Kelli O'Connell, Honglin Hao, Eloise Parrish, Kathleen Conway, Paul B Googe, David W Ollila, Stergios J Moschos, Eva Hernando, Douglas Hanniford, Diana Argibay, Christopher I Amos, Jeffrey E Lee, Iman Osman, Li Luo, Pei-Fen Kuan, Arshi Aurora, Bonnie E Gould Rothberg, Marcus W Bosenberg, Meg R Gerstenblith, Cheryl Thompson, Paul N Bogner, Ivan P Gorlov, Sheri L Holmen, Elise K Brunsgaard, Yvonne M Saenger, Ronglai Shen, Venkatraman Seshan, Eduardo Nagore, Marc S Ernstoff, Klaus J Busam, Colin B Begg, Nancy E Thomas, Marianne Berwick, InterMEL Consortium

    Published 2023-01-01
    Get full text
    Article

Search Tools: